Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Payne

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Journal of the American Medical Informatics Association : JAMIA|June 11, 2024
Cumulus: a federated electronic health record-based learning system powered by Fast Healthcare Interoperability Resources and artificial intelligenceAndrew J McMurry, Daniel I Gottlieb, Timothy A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Cumulus: A federated EHR-based learning system powered by FHIR and AIAndrew J McMurry, Daniel I Gottlieb, Timothy A Miller, et al.
Nature Microbiology|May 29, 2019
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibodyThomas A Rawlinson, Natalie M Barber, Franziska Mohring, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
Frontiers in Immunology|September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamicsJo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
The Journal of Infectious Diseases|June 17, 2016
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAPTommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Elife|March 2, 2021
Mapping immune variation and <i>var</i> gene switching in naive hosts infected with <i>Plasmodium falciparum</i>Kathryn Milne, Alasdair Ivens, Adam J Reid, et al.
Journal of the American Medical Informatics Association : JAMIA|June 11, 2024
Cumulus: a federated electronic health record-based learning system powered by Fast Healthcare Interoperability Resources and artificial intelligenceAndrew J McMurry, Daniel I Gottlieb, Timothy A Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Cumulus: A federated EHR-based learning system powered by FHIR and AIAndrew J McMurry, Daniel I Gottlieb, Timothy A Miller, et al.
Nature Microbiology|May 29, 2019
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibodyThomas A Rawlinson, Natalie M Barber, Franziska Mohring, et al.
JCI Insight|January 24, 2023
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccineCarolyn M Nielsen, Jordan R Barrett, Christine Davis, et al.
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
JCI Insight|June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodiesRuth O Payne, Sarah E Silk, Sean C Elias, et al.
Frontiers in Immunology|September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamicsJo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
The Journal of Infectious Diseases|June 17, 2016
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAPTommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
Pageof 21